Nucleocytoplasmic shuttling activity of ataxin-3

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Macedo Ribeiro, Sandra ^a   Cortes, Luísa ^b   Maciel, Patrícia ^c   Carvalho, Ana Luísa ^b,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ATAXIN 3; EXPORTIN 1; GREEN FLUORESCENT PROTEIN; LEPTOMYCIN B; LYSINE; POLYGLUTAMINE; PROTEIN JOSEPHIN; UBIQUITIN; UNCLASSIFIED DRUG; ATXN3 PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL NUCLEUS; CELL STRAIN COS7; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; MACHADO JOSEPH DISEASE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; YEAST CELL; ANIMAL; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; METABOLISM; MOLECULAR GENETICS; NERVE CELL; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN TRANSPORT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; GREEN FLUORESCENT PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN TRANSPORT; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 67149129949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005834     Document Type: Article

References (68)

1. Chai Y, Berke SS, Cohen RE, Paulson HL (2004) Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 279: 3605-3611.
2. Burnett B, Li F, Pittman RN (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet 12: 3195-3205.
3. Masino L, Musi V, Menon RP, Fusi P, Kelly G, et al. (2003) Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail. FEBS Lett 549: 21-25.
4. Maciel P, Costa MC, Ferro A, Rousseau M, Santos CS, et al. (2001) Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol 58: 1821-1827.
5. Tait D, Riccio M, Sittler A, Scherzinger E, Santi S, et al. (1998) Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum Mol Genet 7: 991-997.
6. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, et al. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19: 333-344.
7. Trottier Y, Cancel G, An-Gourfinkel I, Lutz Y, Weber C, et al. (1998) Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol Dis 5: 335-347.
8. Warrick JM, Morabito LM, Bilen J, Gordesky-Gold B, Faust LZ, et al. (2005) Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell 18: 37-48.
9. Burnett BG, Pittman RN (2005) The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc Natl Acad Sci U S A 102: 4330-4335.
10. Wang Q, Li L, Ye Y (2006) Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J Cell Biol 174: 963-971.
11. Li F, Macfarlan T, Pittman RN, Chakravarti D (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem 277: 45004-45012.
12. Evert BO, Araujo J, Vieira-Saecker AM, de Vos RA, Harendza S, et al. (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J Neurosci 26: 11474-11486.
13. Ross CA, Wood JD, Schilling G, Peters MF, Nucifora FC Jr, et al. (1999) Polyglutamine pathogenesis. Philos Trans R Soc Lond B Biol Sci 354: 1005-1011.
14. Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23: 217-247.
15. Sun J, Xu H, Negi S, Subramony SH, Hebert MD (2007) Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing. J Neurosci Res 85: 2306-2317.
16. Sequeiros J, Coutinho P (1993) Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol 61: 139-153.
17. Schmidt T, Landwehrmeyer GB, Schmitt I, Trottier Y, Auburger G, et al. (1998) An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol 8: 669-679.
18. Orr HT (2001) Beyond the Qs in the polyglutamine diseases. Genes Dev 15: 925-932.
19. Paulson H (2003) Polyglutamine neurodegeneration: minding your Ps and Qs. Nat Med 9: 825-826.
20. Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, et al. (2008) Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature.
21. Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3: 291-304.
22. Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26: 44-50.
23. DiFiglia M (2002) Huntingtin fragments that aggregate go their separate ways. Mol Cell 10: 224-225.
24. Schilling G, Savonenko AV, Klevytska A, Morton JL, Tucker SM, et al. (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Hum Mol Genet 13: 1599-1610.
25. Benn CL, Landles C, Li H, Strand AD, Woodman B, et al. (2005) Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease. Hum Mol Genet 14: 3065-3078.
26. Yang W, Dunlap JR, Andrews RB, Wetzel R (2002) Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet 11: 2905-2917.
27. Jackson WS, Tallaksen-Greene SJ, Albin RL, Detloff PJ (2003) Nucleocytoplasmic transport signals affect the age at onset of abnormalities in knock-in mice expressing polyglutamine within an ectopic protein context. Hum Mol Genet 12: 1621-1629.
28. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, et al. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95: 41-53.
29. Irwin S, Vandelft M, Pinchev D, Howell JL, Graczyk J, et al. (2005) RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci 118: 233-242.
30. Kaytor MD, Duvick LA, Skinner PJ, Koob MD, Ranum LP, et al. (1999) Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 8: 1657-1664.
31. Orr HT (2001) Qs in the nucleus. Neuron 31: 875-876.
32. Taylor J, Grote SK, Xia J, Vandelft M, Graczyk J, et al. (2006) Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal. J Biol Chem 281: 2730-2739.
33. Xia J, Lee DH, Taylor J, Vandelft M, Truant R (2003) Huntingtin contains a highly conserved nuclear export signal. Hum Mol Genet 12: 1393-1403.
34. Cornett J, Cao F, Wang CE, Ross CA, Bates GP, et al. (2005) Polyglutamine expansion of huntingtin impairs its nuclear export. Nat Genet 37: 198-204.
35. Bichelmeier U, Schmidt T, Hubener J, Boy J, Ruttiger L, et al. (2007) Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci 27: 7418-7428.
36. Alves S, Regulier E, Nascimento-Ferreira I, Hassig R, Dufour N, et al. (2008) Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Hum Mol Genet 17: 2071-2083.
37. Chen X, Tang TS, Tu H, Nelson O, Pook M, et al. (2008) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci 28: 12713-12724.
38. Goti D, Katzen SM, Mez J, Kurtis N, Kiluk J, et al. (2004) A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci 24: 10266-10279.
39. Rhee Y, Gurel F, Gafni Y, Dingwall C, Citovsky V (2000) A genetic system for detection of protein nuclear import and export. Nat Biotechnol 18: 433-437.
40. Kaiser C, Michaelis S, Mitchell A (1994) Methods in yeast genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
41. Stachel SE, An G, Flores C, Nester EW (1985) A Tn3 lacZ transposon for the random generation of beta-galactosidase gene fusions: application to the analysis of gene expression in Agrobacterium. Embo J 4: 891-898.
42. Henderson BR, Eleftheriou A (2000) A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp Cell Res 256: 213-224.
43. la Cour T, Gupta R, Rapacki K, Skriver K, Poulsen FM, et al. (2003) NESbase version 1.0: a database of nuclear export signals. Nucleic Acids Res 31: 393-396.
44. Paulson HL, Das SS, Crino PB, Perez MK, Patel SC, et al. (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 41: 453-462.
45. Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8: 673-682.
46. Kudo N, Khochbin S, Nishi K, Kitano K, Yanagida M, et al. (1997) Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem 272: 29742-29751.
47. Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, et al. (1998) Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 242: 540-547.
48. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, et al. (2007) Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem 282: 5101-5105.
49. Pemberton LF, Paschal BM (2005) Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 6: 187-198.
50. Sorokin AV, Kim ER, Ovchinnikov LP (2007) Nucleocytoplasmic transport of proteins. Biochemistry (Mosc) 72: 1439-1457.
51. Terry LJ, Shows EB, Wente SR (2007) Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318: 1412-1416.
52. Yang B, Zhu W, Johnson LB, White FF (2000) The virulence factor AvrXa7 of Xanthomonas oryzae pv. oryzae is a type III secretion pathway-dependent nuclear-localized double-stranded DNA-binding protein. Proc Natl Acad Sci U S A 97: 9807-9812.
53. Patel SS, Belmont BJ, Sante JM, Rexach MF (2007) Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex. Cell 129: 83-96.
54. Chow MK, Paulson HL, Bottomley SP (2004) Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. J Mol Biol 335: 333-341.
55. Gales L, Cortes L, Almeida C, Melo CV, do Carmo Costa M, et al. (2005) Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. J Mol Biol 353: 642-654.
56. Masino L, Nicastro G, Menon RP, Dal Piaz F, Calder L, et al. (2004) Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J Mol Biol 344: 1021-1035.
57. Perez MK, Paulson HL, Pittman RN (1999) Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum Mol Genet 8: 2377-2385.
58. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, et al. (2003) Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A 100: 8892-8897.
59. Mingot JM, Bohnsack MT, Jakle U, Gorlich D (2004) Exportin 7 defines a novel general nuclear export pathway. Embo J 23: 3227-3236.
60. Kutay U, Guttinger S (2005) Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol 15: 121-124.
61. Paraskeva E, Izaurralde E, Bischoff FR, Huber J, Kutay U, et al. (1999) CRM1-mediated recycling of snurportin 1 to the cytoplasm. J Cell Biol 145: 255-264.
62. Giannini A, Mazor M, Orme M, Vivanco M, Waxman J, et al. (2004) Nuclear export of alpha-catenin: overlap between nuclear export signal sequences and the beta-catenin binding site. Exp Cell Res 295: 150-160.
63. Yang Y, Ma J, Chen Y, Wu M (2004) Nucleocytoplasmic shuttling of receptor-interacting protein 3 (RIP3): identification of novel nuclear export and import signals in RIP3. J Biol Chem 279: 38820-38829.
64. Eulalio A, Nunes-Correia I, Carvalho AL, Faro C, Citovsky V, et al. (2006) Nuclear export of African swine fever virus p37 protein occurs through two distinct pathways and is mediated by three independent signals. J Virol 80: 1393-1404.
65. Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, et al. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 143: 1457-1470.
66. Chai Y, Shao J, Miller VM, Williams A, Paulson HL (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A 99: 9310-9315.
67. Bilen J, Bonini NM (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 3: 1950-1964.
68. Gouet P, Courcelle E, Stuart DI, Metoz F (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.